BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Desmoid Tumor Research Foundation - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Desmoid Tumor Research Foundation
X-ORIGINAL-URL:https://dtrf.org
X-WR-CALDESC:Events for The Desmoid Tumor Research Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260512T180000
DTEND;TZID=America/New_York:20260512T190000
DTSTAMP:20260426T133845
CREATED:20260407T131620Z
LAST-MODIFIED:20260408T131955Z
UID:10000049-1778608800-1778612400@dtrf.org
SUMMARY:Navigating Desmoid Tumor Treatment Options & Insights on Zolucatetide (FOG-001)
DESCRIPTION:Join us for our upcoming webinar\, “Navigating Desmoid Tumor Treatment Options & Insights on Zolucatetide (FOG-001)” with Dr. Gregory Cote\, DTRF Medical Advisory Board Member and medical oncologist at Mass General Brigham Cancer Institute to explore current treatment options for people living with desmoid tumors.  \nThis session will include a high-level overview of today’s treatment landscape\, including gamma secretase inhibitor therapies (GSIs)\, sorafenib\, chemotherapy and non-drug treatment options\, as well as emerging clinical trials. Dr. Cote will share early updates on zolucatetide (formerly known as FOG-001)\, including how it works within the Wnt/β-catenin pathway and how it differs from other available treatments. Together\, we’ll walk through what is currently known about the trial\, including how the study is structured\, early signals of effectiveness\, and what patients should understand about potential side effects and tradeoffs. \nThe discussion will also highlight how patients and their care teams can approach decision-making around experimental therapies\, balancing potential benefits\, risks\, and access considerations. This webinar is designed to help patients and caregivers better understand their options and feel more informed when discussing treatment decisions with their medical team. \nWe’ll reserve dedicated time for an in-depth Q&A\, giving you the opportunity to ask Dr. Cote your questions and hear directly from a leading expert. \nRegister today!
URL:https://dtrf.org/event/navigating-desmoid-tumor-treatment-options-insights-on-zolucatetide-fog-001/
CATEGORIES:Caregivers,Clinicians,Connection,Education,Patients
ATTACH;FMTTYPE=image/png:https://dtrf.org/wp-content/uploads/2026/04/Cote_webinar_2026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260628
DTEND;VALUE=DATE:20260629
DTSTAMP:20260426T133845
CREATED:20260203T214106Z
LAST-MODIFIED:20260203T214643Z
UID:10000046-1782604800-1782691199@dtrf.org
SUMMARY:Okanagan Graveller Cycling Event
DESCRIPTION:The Okanagan Graveller cycling event benefits the Desmoid Tumour Foundation of Canada (DFC)\, a long-standing partner of DTRF. Participate or register for the event by clicking visiting the registration page. \nThe DTRF and DFC are currently collaborating and co-funding two multi-year research grants focused on spontaneous regression in desmoid tumors to help advance shared scientific priorities for the global desmoid community. \n  \n  \n 
URL:https://dtrf.org/event/okanagan-graveller-cycling-event/
CATEGORIES:Connection,Fundraising,Patients
ATTACH;FMTTYPE=image/png:https://dtrf.org/wp-content/uploads/2026/02/OG_1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260925
DTEND;VALUE=DATE:20260927
DTSTAMP:20260426T133845
CREATED:20260316T124818Z
LAST-MODIFIED:20260316T124818Z
UID:10000048-1790294400-1790467199@dtrf.org
SUMMARY:2026 DTRF "Together We Will" Weekend
DESCRIPTION:The annual DTRF Together We Will Weekend brings together patients\, caregivers\, researchers\, clinicians and industry professionals to connect\, collaborate\, and learn together. \nFeatured events include: \n\nFriday\, Sept. 25th: Designed for researchers and medical professionals only\, the DTRF International Research Workshop is a critically important\, collaborative event for experts in desmoid tumor research from a variety of disciplines. The Research Workshop presents the latest information on desmoid treatments and research\, and facilitates new collaborations to move the science forward each year.\nSaturday\, Sept. 26th: The DTRF Annual Patient Meeting is our signature patient and caregiver event. The meeting includes educational presentations by clinicians and researchers\, community networking\, Q&A sessions with leading desmoid experts\, and an interactive Mock Tumor Board session. All content is geared toward topics of interest to our patient and caregiver community.\n\nThank you to our Presenting Sponsor\, SpringWorks Therapeutics and Silver Sponsor\, Immunome\, Inc. for supporting this annual event. \n2026 registration and more event details will be coming soon!
URL:https://dtrf.org/event/2026-dtrf-together-we-will-weekend-1/
CATEGORIES:Awareness,Caregivers,Clinicians,Connection,Education,Patients,Research,Researchers
ATTACH;FMTTYPE=image/png:https://dtrf.org/wp-content/uploads/2026/03/TWW_2026.png
END:VEVENT
END:VCALENDAR